Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy

Brachytherapy (BT) is widely used for salvage therapy in patients with biochemical failure (BF) after radiotherapy for prostate cancer (PCa). Although low-dose-rate (LDR) and high-dose-rate (HDR) BT are both used for salvage therapy, it is not clear whether there are any differences between these two approaches in terms of efficacy or toxicity in this setting. Therefore, we review the institutional experience of the members of the Urological Tumour Working Group (URONCOR) of the Spanish Society of Radiation Oncology (SEOR) to compare these two techniques.

Source: Radiotherapy and Oncology - September 26, 2019 Category: Radiology Authors: Iv án Henríquez López, Carmen González-San Segundo, Jesús Olivera Vegas, Cristina Gutierrez, Asunción Hervas, María Ángeles Cabeza Rodriguez, Jeannette Valero Albarrán, Silvia Rodríguez Villalba, Ana Álvarez Gonzalez, Gemma Sancho Pardo, Almude Tags: Technical Note Source Type: research